A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 12523 participants.

Also called NCT05702034

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 12,523 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05702034
  • EU CT 2022-501176-26-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong SAR China, Hungary, India, Israel, Italy, Japan, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, Portugal, Romania, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Türkiye, United Kingdom, Vietnam (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05702034. Randomized; quadruple masking; primary purpose treatment. Start 2023-02-15 (actual); primary completion 2026-10-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Acronym
LIBREXIA-STROK
Condition
Ischemic Stroke; Ischemic Attack, Transient
Intervention (Drug)
Milvexian
Intervention (Drug)
Placebo
Lead sponsor
Janssen Research & Development, LLC (class: industry)
Collaborator
Bristol Myers Squibb Company (BMS) (class: not stated)

Record details

Record id
cardio:ct-nct05702034
Content hash
b3c7b78f397e6d3aa6a12d30f1f5d72f691853e962e6ea8c4be920874b9efcbd